Brian Hubbard
Chief Executive Officer at Anji Pharmaceuticals, Inc.
Brian Hubbard active positions
| Companies | Position | Start | End |
|---|---|---|---|
Sprout Bioventures
 Sprout Bioventures Investment ManagersFinance Sprout Bioventures (Sprout Bioventures) is a venture capital firm founded in 1900. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 2017-12-31 | - |
Anji Pharmaceuticals, Inc.
 Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anji Pharmaceuticals, Inc. engages in discovery and development of medicines for human genetics. The company is headquartered in Cambridge, MA. | Chief Executive Officer | 2018-01-31 | - |
Career history of Brian Hubbard
Former positions of Brian Hubbard
| Companies | Position | Start | End |
|---|---|---|---|
Dogma Therapeutics, Inc.
 Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dogma Therapeutics, Inc. developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease. The company is headquartered in Boxford, MA. | Chief Executive Officer | 2015-07-31 | 2020-08-01 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Director of Research - Equity | 2011-09-30 | 2015-08-01 |
Merck Global Health Innovation LLC
 Merck Global Health Innovation LLC Investment ManagersFinance Merck Global Health Innovation LLC (Merck Global Health) is a venture capital subsidiary of Merck & Co., Inc. founded in 2010. The firm is headquartered in Rahway, New Jersey. | Director of Research - Equity | 2008-02-29 | 2011-09-01 |
| NOVARTIS AG | Director of Research - Equity | 2001-12-31 | 2008-01-01 |
Training of Brian Hubbard
| The College of William & Mary | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
| Harvard Medical School | Graduate Degree |
Statistics
International
| United States | 9 |
| Switzerland | 2 |
Operational
| Director of Research - Equity | 3 |
| Chief Executive Officer | 2 |
| Private Equity Investor | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private companies | 5 |
|---|---|
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Merck Global Health Innovation LLC
Merck Global Health Innovation LLC Investment ManagersFinance Merck Global Health Innovation LLC (Merck Global Health) is a venture capital subsidiary of Merck & Co., Inc. founded in 2010. The firm is headquartered in Rahway, New Jersey. | Finance |
Sprout Bioventures
Sprout Bioventures Investment ManagersFinance Sprout Bioventures (Sprout Bioventures) is a venture capital firm founded in 1900. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Anji Pharmaceuticals, Inc.
Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anji Pharmaceuticals, Inc. engages in discovery and development of medicines for human genetics. The company is headquartered in Cambridge, MA. | Health Technology |
Dogma Therapeutics, Inc.
Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dogma Therapeutics, Inc. developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease. The company is headquartered in Boxford, MA. | Health Technology |
- Stock Market
- Insiders
- Brian Hubbard
- Experience
